Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Test Detects TB in HIV Patients

By HospiMedica staff writers
Posted on 28 Apr 2006
A recent study has confirmed that a new test is able to detect tuberculosis (TB) in HIV patients whose immune systems are severely compromised.

Oxford Immunotec (Abingdon, UK) announced that the study, which was performed at the Chelsea and Westminster hospital (London, UK), showed that the company's T-Spot.TB test is able to detect TB in HIV patients, even when their CD4 T cell count is less than 200 cells/µl. More...
The study also confirmed the ability of the T-Spot.TB to be used as a "rule-out” test for TB in HIV patients. The results of the study were presented at the annual meeting of the British HIV Association in Brighton (UK) in March 2006.

T-Spot is a simple, accurate method of studying a person's cellular immune response to infection, and can be applied to monitor any major disease involving a T cell response. T-Spot.TB is the first test from Oxford Immunotec using T-Spot technology. An in vitro T cell measurement assay, it diagnoses TB disease and latent TB infection. Incorporating a positive control, the T-Spot.TB test enables the user to distinguish a genuine negative result from an inconclusive one that is the result of a technical failure.

T-Spot.TB is approved for sale in Europe and is designed to replace the 115-year old tuberculin skin test.



Related Links:
Oxford Immunotec
Chelsea and Westminster Hospital

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.